Prognosis value of positron emission tomography using F18-fluorodeoxyglucose (FDG-PET) in the setting of ASCT in patients with high grade non-Hodgkin lymphoma (HGNHL).

被引：0
|
作者：
Bodet-Milin, C.
Rolland, V.
Oudoux, A.
Aansquer, C.
Le Goille, S.
Valette, F.
Rousseau, C.
Dupas, B.
Moreau, P.
Harrousseau, J.
Kraeber-Bodere, F.
机构：
[1] Univ Hosp, Nantes, France
[2] Ctr Canc, Nantes, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [11] Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma
    Pelosi, E.
    Pregon, P.
    Penna, D.
    Deandreis, D.
    Chiappella, A.
    Limerutti, G.
    Vitolo, U.
    Mancini, M.
    Bisi, G.
    Gallo, E.
    RADIOLOGIA MEDICA, 2008, 113 (04): : 578 - 590
  • [12] Prognosis Value of [18f] FDG-PET Prior Versus after Autologous Stem Cells Transplantation in High Grade Non-Hodgkin's Lymphoma
    Roland, Virginie
    Milin, Caroline Bodet
    Moreau, Anne
    Gastinne, Thomas
    Mahe, Beatrice
    Dubruille, Viviane
    Maisonneuve, Herve
    Morineau, Nadine
    Moreau, Philippe
    Jardel, Henri
    Planche, Lucie
    Moreau, Philippe
    Harousseau, Jean-Luc
    Bodere, Francoise Kraeber
    Le Gouill, Steven
    BLOOD, 2008, 112 (11) : 759 - 759
  • [13] Prognostic value of quantitative parameters derived on initial staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with high-grade non-Hodgkin's lymphoma
    Manohar, Kuruva
    Mittal, Bhagwant R.
    Bhattacharya, Anish
    Malhotra, Pankaj
    Varma, Subhash
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (09) : 974 - 981
  • [14] THE SIGNIFICANCE AND OUTCOME OF THE FINDING OF PERSISTENT LOW GRADE UPTAKE ON FUNCTIONAL IMAGING USING 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG-PET) IN LYMPHOMA PATIENTS
    Alwan, F.
    Zemenides, S.
    Hughes, D.
    Cwynarski, K.
    Martin, A.
    Wagner, T.
    Kyriakou, C.
    McNamara, C.
    HAEMATOLOGICA, 2014, 99 : 711 - 711
  • [15] The prognostic value of 18-FDG positron emission tomography in T cell non-Hodgkin lymphoma
    R Eslick
    L Dunlop
    M Lin
    D Hsu
    S Ling
    Blood Cancer Journal, 2017, 7 : e556 - e556
  • [16] The prognostic value of 18-FDG positron emission tomography in T cell non-Hodgkin lymphoma
    Eslick, R.
    Dunlop, L.
    Lin, M.
    Hsu, D.
    Ling, S.
    BLOOD CANCER JOURNAL, 2017, 7 : e556 - e556
  • [17] 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) staging of esophageal cancer
    Jager, P. L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 37 - 37
  • [18] Positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) in the diagnosis of liver tumors
    Fujimoto, Masazumi
    Toda, Yasunobu
    Inai, Maki
    Ishihara, Maki
    Asagoe, Kensuke
    Kawai, Toshihide
    Mizuta, Kazuhiko
    Kudo, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A174 - A174
  • [19] The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma
    Dunleavy, Kieron
    Mikhaeel, George
    Sehn, Laurie H.
    Hicks, Rodney J.
    Wilson, Wyndham H.
    LEUKEMIA & LYMPHOMA, 2010, 51 : 28 - 33
  • [20] F-18FDG positron emission tomography in primary breast non-Hodgkin's lymphoma
    Bakheet, SM
    Bakheet, R
    Ezzat, A
    Tulbah, A
    Durakovic, A
    Hussain, S
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (04) : 299 - 301
12345